Developments Tetra Bio-Pharma posts positive initial data from ongoing Phase 2 trials of QIXLEEF Tetra Bio-Pharma (TSX:TBP; OTCQB:TBPMF; FRA:JAM1) reported positive initial clinical data from its ongoing Phase 2 REBORN 1 and PLENITUDE trials of QIXLEEF for cancer pain. QIXLEEF is a botanical inhaled investigational... November 29, 2021